News & Updates
Showing Respirology articles
Showing
Show Multimedia Only

Sotrovimab benefits select hospitalized COVID-19 patients
23 Jan 2026
byAudrey Abella
In the RECOVERY* trial, the neutralizing monoclonal antibody (mAb) sotrovimab reduces mortality in hospitalized patients with COVID-19 pneumonia with a high baseline serum SARS-CoV-2 antigen concentration. However, this was not the case in the overall population.
Sotrovimab benefits select hospitalized COVID-19 patients
23 Jan 2026
Zongertinib shows promise in Asians with advanced HER2-mutant NSCLC
18 Jan 2026
byStephen Padilla
Treatment with zongertinib in Asian patients with advanced HER2-mutant nonsmall cell lung cancer (NSCLC), who have received prior systemic therapy, delivers robust efficacy and elicits an acceptable safety profile, consistent with the overall global analysis, reports a China study.







